Aesthetics Expansion Allergan operates within AbbVie after acquisition, positioning a strong cross-sell opportunity across AbbVie's broader immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology portfolios to accelerate Aesthetics product adoption.

Therapeutic Synergy Leveraging AbbVie’s focus on inflammatory bowel disease data presentations and long-term outcomes, tailor B2B conversations around collaborative research, clinical data access, and co marketing of combined therapy pipelines with Allergan Aesthetics to drive cross therapeutic uptake.

Scale & Reach AbbVie’s sizeable global footprint and high market value, combined with Allergan’s 5000–10000 employees, enables enterprise sales motions targeting large healthcare systems, contract manufacturers, and international distributors for expanded product placement and services.

Digital Backbone Utilize the tech stack including Google BigQuery, Shopify and Smartsheet to offer data driven pricing, digital merchandising, and streamlined order fulfillment, appealing to enterprise customers seeking efficiency and analytics in large scale purchases.

Market Leadership Capitalizing on AbbVie’s leadership in multiple therapeutic areas and recognition as a top workplace, position Allergan Aesthetics and AbbVie as trusted partners for innovation, clinical evidence generation, and long term customer support to win loyalty among hospitals, clinics, and specialty practices.